vs

Side-by-side financial comparison of AST SpaceMobile, Inc. (ASTS) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

AST SpaceMobile, Inc. is the larger business by last-quarter revenue ($54.3M vs $44.6M, roughly 1.2× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). PACIFIC BIOSCIENCES OF CALIFORNIA, INC. runs the higher net margin — -90.4% vs -136.2%, a 45.8% gap on every dollar of revenue. On growth, AST SpaceMobile, Inc. posted the faster year-over-year revenue change (2758.2% vs 13.8%). PACIFIC BIOSCIENCES OF CALIFORNIA, INC. produced more free cash flow last quarter ($-19.9M vs $-330.7M).

AST SpaceMobile, Inc. is a publicly traded satellite designer and manufacturer based in Midland, Texas, United States. The company is building the SpaceMobile satellite constellation, a space-based cellular broadband network designed to connect directly to standard, unmodified smartphones. The network is intended to deliver 4G and 5G broadband coverage globally, particularly in remote and underserved regions.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

ASTS vs PACB — Head-to-Head

Bigger by revenue
ASTS
ASTS
1.2× larger
ASTS
$54.3M
$44.6M
PACB
Growing faster (revenue YoY)
ASTS
ASTS
+2744.3% gap
ASTS
2758.2%
13.8%
PACB
Higher net margin
PACB
PACB
45.8% more per $
PACB
-90.4%
-136.2%
ASTS
More free cash flow
PACB
PACB
$310.8M more FCF
PACB
$-19.9M
$-330.7M
ASTS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASTS
ASTS
PACB
PACB
Revenue
$54.3M
$44.6M
Net Profit
$-74.0M
$-40.4M
Gross Margin
37.1%
Operating Margin
-175.0%
-92.3%
Net Margin
-136.2%
-90.4%
Revenue YoY
2758.2%
13.8%
Net Profit YoY
-106.3%
-1802.7%
EPS (diluted)
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTS
ASTS
PACB
PACB
Q4 25
$54.3M
$44.6M
Q3 25
$14.7M
$38.4M
Q2 25
$39.8M
Q1 25
$37.2M
Q4 24
$39.2M
Q3 24
$40.0M
Q2 24
$36.0M
Q1 24
$38.8M
Net Profit
ASTS
ASTS
PACB
PACB
Q4 25
$-74.0M
$-40.4M
Q3 25
$-122.9M
$-38.0M
Q2 25
$-41.9M
Q1 25
$-426.1M
Q4 24
$2.4M
Q3 24
$-60.7M
Q2 24
$-173.3M
Q1 24
$-78.2M
Gross Margin
ASTS
ASTS
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
ASTS
ASTS
PACB
PACB
Q4 25
-175.0%
-92.3%
Q3 25
-1109.0%
-101.1%
Q2 25
-112.8%
Q1 25
-1154.5%
Q4 24
-390.1%
Q3 24
-160.3%
Q2 24
-488.3%
Q1 24
-209.6%
Net Margin
ASTS
ASTS
PACB
PACB
Q4 25
-136.2%
-90.4%
Q3 25
-833.7%
-98.9%
Q2 25
-105.4%
Q1 25
-1146.8%
Q4 24
6.0%
Q3 24
-151.9%
Q2 24
-481.3%
Q1 24
-201.4%
EPS (diluted)
ASTS
ASTS
PACB
PACB
Q4 25
$-0.11
Q3 25
$-0.13
Q2 25
$-0.14
Q1 25
$-1.44
Q4 24
$-0.44
Q3 24
$-0.22
Q2 24
$-0.64
Q1 24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTS
ASTS
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$4.3B
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.4B
$5.3M
Total Assets
$5.0B
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTS
ASTS
PACB
PACB
Q4 25
$4.3B
$279.5M
Q3 25
$2.4B
$298.7M
Q2 25
$314.7M
Q1 25
$343.1M
Q4 24
$389.9M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Stockholders' Equity
ASTS
ASTS
PACB
PACB
Q4 25
$2.4B
$5.3M
Q3 25
$1.6B
$36.1M
Q2 25
$61.5M
Q1 25
$91.6M
Q4 24
$506.6M
Q3 24
$453.1M
Q2 24
$492.7M
Q1 24
$649.0M
Total Assets
ASTS
ASTS
PACB
PACB
Q4 25
$5.0B
$784.1M
Q3 25
$2.6B
$803.2M
Q2 25
$825.5M
Q1 25
$860.8M
Q4 24
$1.3B
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTS
ASTS
PACB
PACB
Operating Cash FlowLast quarter
$65.0M
$-19.1M
Free Cash FlowOCF − Capex
$-330.7M
$-19.9M
FCF MarginFCF / Revenue
-609.0%
-44.6%
Capex IntensityCapex / Revenue
728.7%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-790.4M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTS
ASTS
PACB
PACB
Q4 25
$65.0M
$-19.1M
Q3 25
$-64.5M
$-18.7M
Q2 25
$-29.4M
Q1 25
$-44.1M
Q4 24
$-30.6M
Q3 24
$-45.5M
Q2 24
$-54.3M
Q1 24
$-75.7M
Free Cash Flow
ASTS
ASTS
PACB
PACB
Q4 25
$-330.7M
$-19.9M
Q3 25
$-302.9M
$-18.8M
Q2 25
$-29.9M
Q1 25
$-45.4M
Q4 24
$-32.3M
Q3 24
$-46.3M
Q2 24
$-55.7M
Q1 24
$-79.6M
FCF Margin
ASTS
ASTS
PACB
PACB
Q4 25
-609.0%
-44.6%
Q3 25
-2055.0%
-48.9%
Q2 25
-75.3%
Q1 25
-122.3%
Q4 24
-82.3%
Q3 24
-115.7%
Q2 24
-154.8%
Q1 24
-205.0%
Capex Intensity
ASTS
ASTS
PACB
PACB
Q4 25
728.7%
1.9%
Q3 25
1617.6%
0.2%
Q2 25
1.4%
Q1 25
3.7%
Q4 24
4.1%
Q3 24
2.0%
Q2 24
4.1%
Q1 24
10.0%
Cash Conversion
ASTS
ASTS
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTS
ASTS

Products$44.4M82%
Other$7.8M14%
Sat Co$2.1M4%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons